Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Clinical trial NCT02102698 · COMPLETED
Trial details
- NCT number
- NCT02102698
- Sponsor
- Emalex Biosciences Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-19
- Primary completion
- 2019-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.